TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,177 | -3.6% | 12,164 | -2.1% | 0.00% | 0.0% |
| Q2 2023 | $195,165 | -38.3% | 12,423 | -35.3% | 0.00% | -33.3% |
| Q1 2023 | $316,484 | -44.7% | 19,204 | -47.7% | 0.00% | -40.0% |
| Q4 2022 | $572,458 | -99.8% | 36,696 | -31.2% | 0.01% | +25.0% |
| Q3 2022 | $346,346,000 | +95050.0% | 53,310 | +105.9% | 0.00% | 0.0% |
| Q2 2022 | $364,000 | +15.6% | 25,894 | +17.9% | 0.00% | +33.3% |
| Q1 2022 | $315,000 | -19.2% | 21,969 | -23.2% | 0.00% | -25.0% |
| Q4 2021 | $390,000 | -34.8% | 28,588 | -21.7% | 0.00% | -33.3% |
| Q3 2021 | $598,000 | -3.5% | 36,528 | -0.9% | 0.01% | -14.3% |
| Q2 2021 | $620,000 | -10.1% | 36,858 | -2.5% | 0.01% | -22.2% |
| Q1 2021 | $690,000 | +198.7% | 37,784 | +196.8% | 0.01% | +200.0% |
| Q4 2020 | $231,000 | – | 12,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |